Development knowledge can increase manufacturing capability and facilitate quality by design

Journal of Pharmaceutical Innovation

Volumn 2, Issue 3-4, 2007, Pages 87-92

  Somma, Russ ^a  

^a SommaTech   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEW DRUG;

ARTICLE; DRUG DESIGN; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG MARKETING; DRUG QUALITY; DRUG RESEARCH; FOOD AND DRUG ADMINISTRATION; KNOWLEDGE; PHARMACEUTICAL ENGINEERING; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROCESS CONTROL; PROCESS DEVELOPMENT; PROCESS MONITORING; PROCESS TECHNOLOGY; PRODUCT DEVELOPMENT; PROFESSIONAL STANDARD; QUALITY CONTROL;

EID: 38349060175     PISSN: 18725120     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12247-007-9017-8     Document Type: Article

References (30)

1. Roth G. Engineering and quality: Quality guidelines. Contract Pharma Jan/ Feb 2007.
2. Draft PQLI Summary Update Report V04, September 17,2007, ISPE PQLI Task Team.
3. Woodcock J. Pharmaceutical quality in the 21st Century - an integrated systems approach, December 6, 2006.
4. Joshi Y, LoBrutto R, Serajuddin ATM. Industry opinion of regulatory influence: The initiative on pharmaceutical cGMPs for the 21st century. Journal of Process Analytical Technology July/August 2006.
5. Nasr MM. A New Pharmaceutical Quality Assessment System (PQAS) for the 21st Century, AAPS Workshop October 2005.
6. QbD Principles to be implemented in future FDA guidance; DIA Dispatch, Oct. 28, 2005.
7. Yu, LX. Implementation of quality by design: Question Based Review, DIA Meeting, June 2006.
8. Chen C. Implementation of ICH Q8 and QbD-an FDA Perspective, PharmaForum Yokohama, June 2006.
9. Gassmann O, von Zedtwitz M. Organization of industrial R&D on a global scale. R&D Management 1998;28(3):147-61.
10. Berridge JC. Quality by design: Integration of prior knowledge and pharmaceutical development into CMC submission and review: An Industry Perspective. AAPS Workshop, October 2005.
11. Krajick K. Medicine from the sea. Smithsonian Magazine May 2004.
12. Hussain AS. Quality by design: Integration of prior knowledge and pharmaceutical development into CMC submission and review: FDA Perspective, AAPS Workshop, October 2005.
13. Parexel's bio/pharmaceutical statistical sourcebook 2007/2008 Editor Mathieu M.P. Parexel International Corp. 2007.
14. Design space to facilitate quality initiative implementation. The Gold Sheet, April 2005.
15. DePalma A. Pharma embraces quality by design. Pharm Manuf September 2006.
16. The FAA and industry guide to product certification, Second Edition, September 2004.
17. Hoiberg C. An industry perspective of how implementing the ICH Q8 guideline may impact the pharmaceutical process development, ISPE Washington Conference, June 2006.
18. Jagota N. An industry perspective on the FDA CMC pilot program. FDA Briefing Document April 2006.
19. Rangaswamy A, Lilien GL. Software tools for new product development. J Mark Res 1997;34(1):177-84.
20. Subramanian M, Rosenthal SR. Global new product development processes: Preliminary findings and research propositions. J Manag Stud 1998;35(6):773-96.
21. Werther WB, Berman E, Vasconcellos E. The future of technology management. Organ Dyn 1994;22(3):20-32.
22. Celik M. Overview of compaction data analysis techniques Drug Dev Ind Pharm 1992;18(6&7):767-810.
23. Castells X, Hu Y, Stewart B, Geoffroy J. Application of quality by design knowledge from site transfers to commercial operations already in progress. Journal of Process Analytical Technology January/February 2006.
24. Popp KF. Organizing technology transfer from research to production. Drug Dev Ind Pharm 1987;13(13):2339-62.
25. Von Doehren PJ, Saint John Forbes F, Shively CD. Approach to the characterization and technology transfer of solid dosage form processes Pharm Technol 1982;6:139-56 Sept.
26. McCready C. Multivariate analysis for manufacturing quality systems. Pharma Manufacturing October 2005.
27. Wechsler J. Regulatory beat: Quality standards to reshape manufacturing. BioPharma International February 1, 2007.
28. Kieffer R, Torbeck L. Validation and process capability. Pharm Technol 1998;22(6):66-76.
29. PQRI working group. Process Robustness-A PQRI White Paper. Pharm Eng November/December 2006.
30. Bush L. The end of process validation as we know it? Pharm Technol August 2, 2005, p. 36.